Granulomatosis with polyangiitis (GPA) is a rare autoimmune disease in which the immune system attacks the walls of small blood vessels, producing clusters of inflamed tissue called granulomas. It primarily strikes the respiratory tract and kidneys but can damage nearly any organ. The condition was known for decades as Wegener’s granulomatosis before an international renaming effort in 2010, and it remains one of the most serious forms of vasculitis, requiring aggressive immunosuppressive treatment and long-term follow-up.
Why the Name Changed
The disease was first comprehensively described in the 1930s by the German pathologist Friedrich Wegener, and for most of the twentieth century it bore his name. In 2010, major rheumatology and nephrology societies formally adopted “granulomatosis with polyangiitis” after evidence surfaced linking Wegener to the Nazi regime.1PubMed. Undisclosed facts in Friedrich Wegener’s links with Nazism The replacement name is not just political housekeeping; it actually describes the pathology. “Granulomatosis” refers to the multifocal areas of necrotizing inflammation that define the disease under a microscope, and “polyangiitis” captures the fact that inflammation hits many different vessels and vessel types throughout the body.2PubMed Central. Nomenclature and classification of vasculitis: lessons learned from granulomatosis with polyangiitis (Wegener’s granulomatosis) You will still see the old name in older medical literature and occasionally in conversation, but GPA is the accepted term today.
How Common Is GPA
GPA is rare in absolute terms but is the most common subtype of ANCA-associated vasculitis (AAV). A large meta-analysis pooling data from studies worldwide found that GPA occurs at a rate of about 9 new cases per million people per year, with an overall prevalence of roughly 97 per million.3PubMed Central. Systematic Review and Metaanalysis of Worldwide Incidence and Prevalence of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis That makes it considerably more common than its sibling conditions, microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis, though still uncommon by any standard. Rates are highest in the Northern Hemisphere and among populations in Europe and the Americas, while the disease appears less frequently in Asian and African populations.4PubMed. Epidemiology and genetics of granulomatosis with polyangiitis The peak age at diagnosis is usually in the 50s to 60s, and men and women are affected at similar rates.
What Causes It
The short answer is that nobody knows the single trigger. GPA is understood to arise from a mix of genetic susceptibility and environmental exposures that together push the immune system into a self-destructive pattern. On the genetic side, genome-wide association studies have repeatedly pointed to a stretch of DNA in the HLA region, specifically the HLA-DPB1*04 allele, as a strong risk factor. One study found that the vast majority of GPA patients carried at least one copy of this allele, with an odds ratio above 6 compared to healthy controls.5Gene. HLA sequencing identifies novel associations and suggests clinical relevance of DPB1*04:01 in ANCA-associated Granulomatosis with polyangiitis That association has been replicated in European and Indian populations alike.6PubMed Central. Association of Granulomatosis With Polyangiitis (Wegener’s) With HLA–DPB1*04 and SEMA6A Gene Variants Evidence From Genome-Wide Analysis Other genes implicated in the disease include CTLA4, PTPN22, and SERPINA1, all of which play roles in immune regulation or protease activity.7PubMed. Genetics and pathophysiology of granulomatosis with polyangiitis (GPA) and its main autoantigen proteinase 3
Among environmental candidates, the bacterium Staphylococcus aureus has attracted the most attention. Chronic nasal carriage of staph is common in GPA patients, and one study found that among those with generalized GPA, chronic carriers faced a roughly fourfold higher risk of relapse compared to non-carriers.8PubMed. Chronic nasal Staphylococcus aureus carriage identifies a subset of newly diagnosed granulomatosis with polyangiitis patients with high relapse rate The hypothesis is that repeated exposure to bacterial proteins may prime or reactivate the abnormal immune response. However, the picture is not clean. A separate study examining patients on rituximab maintenance therapy found no link between nasal staph carriage and relapse risk.9PeerJ. Staphylococcus Aureus carriage and long-term Rituximab treatment for Granulomatosis with polyangiitis The relationship likely depends on the treatment context and the patient’s underlying immune state, and staph is best understood as a possible aggravating factor rather than a proven cause.
How GPA Damages Blood Vessels
The central villain in GPA’s disease process is a group of autoantibodies called anti-neutrophil cytoplasmic antibodies (ANCA). In most GPA patients, these antibodies target a protein called proteinase 3 (PR3) that sits on the surface of neutrophils, which are white blood cells normally involved in fighting infection. When ANCA bind to neutrophils, they lock onto the cells in two ways at once: part of the antibody grabs PR3 while another part grabs receptors on the neutrophil surface. This dual binding activates the neutrophil inappropriately.10PubMed Central. Pathogenicity of Proteinase 3-Anti-Neutrophil Cytoplasmic Antibody in Granulomatosis With Polyangiitis: Implications as Biomarker and Future Therapies
Once activated, neutrophils release destructive enzymes and form structures called neutrophil extracellular traps (NETs), which are web-like tangles of DNA and proteins that the cell expels. These traps damage the inner lining of blood vessels directly and also activate the complement system, a cascade of proteins that amplifies inflammation.11PubMed Central. Neutrophil Extracellular Traps in ANCA-Associated Vasculitis To make matters worse, the contents of those NETs include the very PR3 protein that ANCA target, creating a feedback loop: damaged tissue releases more PR3, which stimulates more ANCA production, which activates more neutrophils.12PubMed Central. Neutrophil Extracellular Traps (NETs) and Vasculitis The result is a self-perpetuating cycle of vessel-wall destruction and granuloma formation.
Symptoms and Organ Involvement
GPA most commonly targets the upper respiratory tract, lungs, and kidneys, but it can affect the skin, eyes, nervous system, joints, and heart. Early symptoms are often deceptively ordinary: a stuffy nose that will not clear, recurring sinusitis, nosebleeds, or a persistent cough. Because these overlap with everyday infections, GPA is frequently misdiagnosed for months before the full picture emerges.13PubMed Central. Granulomatosis with polyangiitis: Common and uncommon presentations
Kidney involvement is one of the most dangerous aspects. When small blood vessels in the kidneys become inflamed, the filtering units start to leak blood and protein into the urine, eventually leading to kidney failure if untreated. This is often silent in the early stages, detectable only through lab work, which is why routine urine and blood tests are essential once GPA is suspected.
Eye and orbital disease deserves special mention because it occurs in close to half of all GPA patients. It can affect virtually every structure of the eye, from the eyelids and tear ducts to the retina and optic nerve.14PubMed Central. Ocular Manifestations of Granulomatosis with Polyangiitis: A Review of the Literature An inflammatory mass behind the eye (orbital pseudotumor) can push the eyeball forward and cause double vision or pain. These orbital masses tend to be associated with PR3-ANCA positivity, while central nervous system involvement is more often linked to a different ANCA pattern targeting myeloperoxidase.15PubMed Central. Ocular and orbital manifestations of granulomatosis with polyangiitis: a systematic review of published cases
Diagnosis and the Role of ANCA Testing
There is no single test that definitively confirms GPA. Diagnosis rests on combining clinical symptoms, blood tests, imaging, and often a tissue biopsy. The ANCA blood test is the most distinctive laboratory marker. In GPA, the typical pattern is a cytoplasmic ANCA (c-ANCA) directed against proteinase 3. A meta-analysis of ANCA testing found that the standard fluorescence-based test for c-ANCA has a sensitivity of about 75% and a specificity above 98%. Newer immunoassays targeting PR3 directly push sensitivity into the 80-87% range while maintaining similarly high specificity.16Elsevier / PubMed Central. The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis In practical terms, a positive PR3-ANCA result in someone with the right symptoms is highly suggestive, but a negative result does not rule the disease out. Roughly 10-20% of GPA patients are ANCA-negative, particularly those with disease limited to the upper airways.
Biopsy remains valuable. In one study of orbital and ophthalmic biopsies, the presence of neutrophil infiltration and vasculitis in the tissue were the features most strongly and independently associated with a later confirmed diagnosis of GPA.17PubMed Central. Histopathological features predictive of a clinical diagnosis of ophthalmic granulomatosis with polyangiitis (GPA) Classical textbook descriptions emphasize granulomas and necrosis, but in practice biopsy specimens do not always show the full triad, and clinicians sometimes have to make the call based on a combination of partial findings.
The Cocaine Mimicker
One diagnostic pitfall worth knowing about is cocaine-induced midline destructive disease, which can look almost identical to GPA. Cocaine damages nasal tissue and, in a cruel biochemical twist, often triggers positive ANCA results. One case series found that over 70% of patients with cocaine-induced nasal destruction tested positive for ANCA, and most showed the PR3-targeting pattern usually associated with GPA.18PubMed. The role of ANCA in the management of cocaine-induced midline destructive lesions or ENT pseudo-granulomatosis with polyangiitis: a London multicentre case series This means that standard blood work alone cannot reliably distinguish the two conditions. Experts recommend urine drug screening for cocaine before diagnosing GPA in any patient who presents with destructive nasal lesions, particularly younger patients.19PubMed Central. Cocaine-induced granulomatosis with polyangiitis-an under-recognized condition The distinction matters enormously: true GPA needs immunosuppression, while cocaine-induced disease needs drug cessation. Giving powerful immune-suppressing drugs to someone whose tissue damage is caused by cocaine would be ineffective and dangerous.
Treatment for Active Disease
When GPA flares or is first diagnosed with serious organ involvement, the immediate goal is to stop the inflammatory attack. This is called induction therapy, and for decades the standard approach was a combination of high-dose corticosteroids with cyclophosphamide, a potent chemotherapy drug. Rituximab, a biologic that depletes B cells (the immune cells that produce antibodies, including ANCA), has increasingly replaced cyclophosphamide as first-line induction. A comparative effectiveness study found that about 73% of patients receiving rituximab achieved remission, compared to about 40% on cyclophosphamide.20PubMed Central. Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With Polyangiitis An earlier randomized trial comparing the two in patients with kidney involvement found similar sustained remission rates, around 76% for rituximab and 82% for cyclophosphamide, though that trial was smaller and the difference was not statistically significant.21PubMed. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis In current practice, rituximab is often preferred because it avoids some of the worst long-term risks of cyclophosphamide, including bladder toxicity and increased cancer risk with cumulative exposure.
One of the most meaningful recent advances has been avacopan, a drug that blocks the receptor for C5a, a fragment of the complement system that helps drive the neutrophil activation and tissue damage described above. In a large randomized trial, avacopan proved noninferior to a standard prednisone taper at inducing remission by 26 weeks and was actually superior for sustained remission at 52 weeks, with about 66% of avacopan-treated patients in sustained remission versus 55% on prednisone.22PubMed. Avacopan for the Treatment of ANCA-Associated Vasculitis The practical significance is that avacopan can substantially reduce or eliminate the need for long courses of steroids, whose side effects, including weight gain, bone loss, diabetes, and infections, are among the biggest quality-of-life burdens for GPA patients.23PubMed Central. Complement Inhibition in ANCA-Associated Vasculitis Safety data pooled across three clinical trials showed that avacopan was actually associated with fewer adverse events and infections than standard treatment.24PubMed Central. Safety of Avacopan for the Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Combined Data From Three Clinical Trials
Plasma exchange, which physically removes ANCA and inflammatory mediators from the blood, was once used in severe cases, particularly those with kidney failure or lung hemorrhage. However, the large PEXIVAS trial found that plasma exchange did not reduce the risk of end-stage kidney disease or improve outcomes for pulmonary hemorrhage.25PubMed Central. Plasma Exchange in ANCA-Associated Vasculitis: A Narrative Review Its role has narrowed considerably as a result, though some clinicians still consider it in life-threatening lung bleeding on a case-by-case basis.
Staying in Remission
Getting GPA under control is only half the battle. The disease has a strong tendency to relapse, and maintenance therapy after remission is essential. Current expert opinion favors prolonged maintenance with low-dose rituximab infusions, typically every six months.26PubMed. How best to manage relapse and remission in ANCA-associated vasculitis The optimal duration is still debated; many specialists continue treatment for at least two to four years, though some patients need it indefinitely.
Not everyone faces the same relapse risk. A French research group developed a scoring system based on three factors at diagnosis: PR3-ANCA positivity, age 75 or younger, and preserved kidney function (estimated filtration rate above 30). Each factor contributes one point. In their validation group, the five-year relapse risk ranged from 8% for patients scoring zero to 76% for those scoring three.27RMD Open. Score to assess the probability of relapse in granulomatosis with polyangiitis and microscopic polyangiitis The counterintuitive finding that better kidney function predicts more relapses likely reflects the fact that patients with more aggressive kidney damage at the outset tend to have a disease phenotype that, once treated, is less prone to cycling back. This kind of risk stratification helps doctors decide how long to continue maintenance therapy and how vigilantly to monitor.
Cardiovascular Risk
GPA is increasingly recognized as a condition that raises the risk of heart disease, even beyond the acute phase of active vasculitis. A Danish registry study following over 1,800 GPA patients found that the risk of heart failure was dramatically elevated in the first three months after diagnosis, with a hazard ratio above 7 compared to the general population. While the risk declined after that early period, it remained roughly doubled even beyond ten years.28Journal of Translational Autoimmunity. Granulomatosis with polyangiitis and cardio vascular co-morbidity in Denmark. A registry-based study of 21 years of follow-up A separate nationwide cohort study confirmed the pattern for heart failure specifically, showing a more than threefold increased rate in the first year that largely normalized after the first year.29The Journal of Rheumatology. Long-term Risk of Heart Failure and Other Adverse Cardiovascular Outcomes in Granulomatosis With Polyangiitis: A Nationwide Cohort Study The acute-phase risk is probably driven by active inflammation in the heart’s small vessels, while the lingering long-term elevation may reflect cumulative vascular damage, medication side effects from steroids and immunosuppressants, or chronic low-grade inflammation. Regardless of the mechanism, the takeaway for patients is that cardiovascular monitoring should be part of long-term GPA care, not just a concern during flares.
GPA in Children
While GPA overwhelmingly affects adults, it can appear in childhood and adolescence. Pediatric GPA can look different from the adult form in important ways. One case series highlighted that skin lesions resembling pyoderma gangrenosum, a type of deep ulceration, can be the very first sign, appearing months before the classic respiratory or kidney involvement that eventually leads to the correct diagnosis. In those cases, the children had prominent facial ulcers and did not respond to antibiotics or standard wound-care medications, but improved dramatically on rituximab.30PubMed Central. Pyoderma gangrenosum-like ulceration as a presenting feature of pediatric granulomatosis with polyangiitis One child in that series initially tested negative for PR3-ANCA, only to convert to positive once systemic symptoms emerged, a reminder that early-stage testing can be misleadingly normal.
The good news is that about 90% of children with GPA achieve remission. The less reassuring news is that around 61% of them relapse, and children tend to experience more blood-count-related complications from treatment, including low white blood cells and low immunoglobulin levels, than adults do.31PubMed Central. Pediatric Presentations of Granulomatosis With Polyangiitis: A Double Case Study Pediatric GPA requires a rheumatologist comfortable with the disease and careful monitoring for these medication side effects.
Fatigue, Mental Health, and Life Beyond the Lab Results
One of the most underappreciated aspects of GPA is the toll it takes on daily life, even when blood tests suggest the disease is under control. Fatigue is consistently reported as the single biggest driver of poor quality of life in ANCA-associated vasculitis. In one study, patients reporting moderate to severe fatigue had dramatically worse physical health scores, and the association held even after accounting for disease activity and organ damage.32PubMed Central. Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis This is not simply the tiredness of being sick. Many patients in remission continue to experience crushing fatigue that limits work, social activity, and exercise.
Depression, anxiety, and sleep disturbances are also common in GPA and, while often mild to moderate in severity, they chip away at quality of life in ways that standard disease-activity scores do not capture.33PubMed. Severity and determinants of psychosocial comorbidities in granulomatosis with polyangiitis and their impact on quality of life These problems tend to be under-addressed in clinical practice, where visits naturally focus on ANCA titers, kidney function, and imaging. Patients benefit from raising these issues proactively, and treatment teams increasingly recognize that managing GPA well means treating the whole person, not just the inflammation markers.